Depression, anxiety and stress after COVID-19 vaccination: A retrospective cross-sectional study among health care providers
- PMID: 36733523
- PMCID: PMC9851821
- DOI: 10.18549/PharmPract.2022.3.2689
Depression, anxiety and stress after COVID-19 vaccination: A retrospective cross-sectional study among health care providers
Abstract
Background: Corona virus disease (COVID-19) is a health concern that produced considerable psychological and physical health challenges to Health care providers (HCPs) internationally.
Aims: This study aims to determine the level of depression, anxiety, and stress after receiving the COVID-19 vaccine among HCPs in Iraq.
Methods: A retrospective cross-sectional study design was used in this study. The participants involved were 700 Iraqi HCPs who received one or two doses from COVID-19 vaccines. The questionnaire was designed and brought to them electronically using Google form and distributed by social media. Then mental health status was measured using a specific depression, anxiety and stress scale named DASS-21. Each domain of the DASS scale was calculated for each subject and DASS-21 scores were compared between different demographic groups.
Results: Females represented a large percentage of participants (80%). The majority of participants had a normal level of DASS-21 after receiving the vaccine. Higher scores were obtained among graduated young age groups also among individuals who have side effects associated with the vaccine.
Conclusions: To the best of our knowledge, this is the first study that assesses mental health after receiving the COVID-19 vaccine in the middle east. The study concluded that HCPs have low DASS-21 scores and this gives us promising results for the use of the COVID-19 vaccine in future.
Keywords: COVID-19; anxiety; depression; health care providers; stress; vaccine.
Copyright: © Pharmacy Practice.
References
-
- 1. Ozamiz-Etxebarria N, Dosil-Santamaria M, Picaza-Gorrochategui M. Stress, anxiety, and depression levels in the initial stage of the COVID-19 outbreak in a population sample in the northern Spain. Cad Saude Publica. 2020;36(4):e00054020. https://doi.org/10.1590/0102-311X00054020 - PubMed
- Ozamiz-Etxebarria N, Dosil-Santamaria M, Picaza-Gorrochategui M. Stress, anxiety, and depression levels in the initial stage of the COVID-19 outbreak in a population sample in the northern Spain. Cad Saude Publica. 2020;36(4):e00054020. doi: 10.1590/0102-311X00054020. - DOI - PubMed
-
- 2. Szmyd B, Karuga FF, Bartoszek A, et al. Attitude and Behaviors towards SARS-CoV-2 Vaccination among Healthcare Workers:A Cross-Sectional Study from Poland. Vaccines (Basel). 2021;9(3):218. https://doi.org/10.3390/vaccines9030218 - PMC - PubMed
- Szmyd B, Karuga FF, Bartoszek A, et al. Attitude and Behaviors towards SARS-CoV-2 Vaccination among Healthcare Workers:A Cross-Sectional Study from Poland. Vaccines (Basel) 2021;9(3):218. doi: 10.3390/vaccines9030218. - DOI - PMC - PubMed
-
- 3. Das R, Hasan MR, Daria S, et al. Impact of COVID-19 pandemic on mental health among general Bangladeshi population:a cross sectional study. BMJ Open. 2021;11(4):e045727. https://doi.org/10.1136/bmjopen-2020-045727 - PMC - PubMed
- Das R, Hasan MR, Daria S, et al. Impact of COVID-19 pandemic on mental health among general Bangladeshi population:a cross sectional study. BMJ Open. 2021;11(4):e045727. doi: 10.1136/bmjopen-2020-045727. - DOI - PMC - PubMed
-
- 4. World Health Organisation. Draft landscape and tracker of COVID-19 candidate vaccines. World Health Organisation (WHO);2020. Available from:https://www.who.int/publications/m/item/draftlandscape-of-covid-19-candi.... Accessed June 17, 2021.
- World Health Organisation. Draft landscape and tracker of COVID-19 candidate vaccines. World Health Organisation (WHO) 2020. [Accessed June 17, 2021]. Available from: https://www.who.int/publications/m/item/draftlandscape-of-covid-19-candi... .
-
- 5. Oliver SE, Gargano JW, Scobie H, et al. The Advisory Committee on Immunization Practices'Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021. MMWR Morb Mortal Wkly Rep. 2021;70(9):329-332. https://doi.org/10.15585/mmwr.mm7009e4 - PMC - PubMed
- Oliver SE, Gargano JW, Scobie H, et al. The Advisory Committee on Immunization Practices'Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021. MMWR Morb Mortal Wkly Rep. 2021;70(9):329–332. doi: 10.15585/mmwr.mm7009e4. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources